Clinical trials
Pulmonary Disease clinical trials
Below are recruiting pulmonary disease clinical trials, each written for real people, not researchers. We’re tracking 551 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04375280Recruiting
Study of mobility problems in people with long-term illnesses
This study observes how people with chronic health conditions affect their ability to move and do everyday activities. It may help researchers better understand mobility limits and what factors influence them.
Clermont-FerrandAges 18–90 - NCT06523270Recruiting
Advanced imaging biobank study
This study collects medical images (CT and MRI scans) and data from adults who are already having scans at the hospital. It creates a biobank to help researchers learn more about health and disease.
MilanAges 18 years+ - NCT06526195Recruiting
A study of CardioMEMS and HeartMate 3 for advanced heart failure
This trial tests if a combination of a tiny lung-artery pressure sensor (CardioMEMS) and a mechanical heart pump (HeartMate 3) is safe and effective for people with advanced heart failure. If you qualify, you'll either get the heart pump plus standard medical therapy, or continue with standard therapy alone and have your pressure monitored remotely.
Phoenix, ArizonaAges 18 years+ - NCT05025774Recruiting
Exercise program study for young heart, leukemia, and lung survivors
This study looks at how an exercise program affects fitness and lung function in young people who are survivors of certain conditions (heart transplant, leukemia, or lung disease from prematurity). The goal is to see whether exercise can improve breathing and overall physical function safely.
Minneapolis, MinnesotaAges 8–25 - NCT00077909Recruiting
Study of Lung Proteins in Patients With Pneumonia
This research study examines proteins in fluid collected from your lungs during a breathing tube procedure (bronchoscopy) to better understand pneumonia. By studying these proteins, researchers hope to improve how doctors diagnose and treat lung infections.
Bethesda, MarylandAges 3–99 - NCT05665556Recruiting
Registry for pulmonary hypertension in connective tissue disease
This trial is a registry that collects health information from people with certain types of pulmonary hypertension linked to connective tissue diseases. It helps doctors understand patterns of disease and outcomes, which can guide future care and studies.
Mexico CityAges 18 years+ - NCT07234032RecruitingPhase 3
Long-term follow-up study of TPIP for PH-ILD
This trial is a long-term follow-up study for people who already completed a previous study of an inhaled treprostinil medication (TPIP) for pulmonary hypertension caused by interstitial lung disease (PH-ILD). It tests whether continued treatment with TPIP is safe and effective over a longer period.
Naples, FloridaAges 18 years+ - NCT07179380RecruitingPhase 3
Inhaled treprostinil for pulmonary hypertension related to interstitial lung disease
This study tests an inhaled powder medication called TPIP (treprostinil palmitil inhalation powder) to see if it can improve symptoms and exercise ability in people who have both interstitial lung disease and pulmonary hypertension. The study will compare TPIP against a placebo (a dummy treatment without the active drug) to understand how well it works and if it is safe.
Phoenix, ArizonaAges 18 years+ - NCT01915511Recruiting
Long-term registry for new or worsening lung scarring
This study collects health information over time from people with newly diagnosed idiopathic pulmonary fibrosis (IPF) or other lung scarring diseases that are getting worse. It’s meant to better understand disease patterns and outcomes, which may help doctors plan future care.
Birmingham, AlabamaAges 21 years+ - NCT07791069Enrolling by invitation
Study of a device to manage blood flow in the lungs for heart disease in young children
This study looks at how well a new device works to control blood flow to the lungs in children with heart problems. It reviews medical records of children who had this device placed in their lung arteries.
Le Plessis-RobinsonAges Up to 3 years - NCT07830602Recruiting
Home breathing and exercise program for interstitial lung disease
This study tests a home-based program of breathing exercises and physical activity for people with interstitial lung disease, aiming to improve breathlessness and daily function.
Chandigarh, ChandigarhAges 18–75 - NCT06526468Recruiting
AI study for diagnosing blood clots in lungs
This study uses artificial intelligence to look at imaging scans from people who might have a pulmonary embolism (a blood clot in the lungs). It aims to help doctors better diagnose and treat this condition.
BeijingAges 14 years+ - NCT04206852Recruiting
Balloon treatment for chronic blood-clot lung vessel disease
This trial tests whether a procedure called balloon pulmonary angioplasty is safe and effective for people with chronic thromboembolic disease in the lungs, especially when surgery isn’t an option. If you have CTEPH, it may help improve lung blood flow and symptoms.
BeijingAges 18 years+ - NCT07874139Recruiting
Study on antibiotic resistance in chronic lung disease
This study looks at antibiotic resistance in people with chronic lung disease by checking their respiratory samples. It aims to understand how resistance develops and help improve treatment.
Ann Arbor, MichiganAges Any age - NCT07704567Recruiting
Using MoblO2 to maintain oxygen levels during activity
This study tests a device called MoblO2 to help people with COPD or interstitial lung disease keep their oxygen levels up during activity. If you normally use oxygen when you walk or exert yourself, this might help you stay active more safely.
Denver, ColoradoAges 25–95 - NCT07641309Recruiting
Health Program for Diabetes, Lung, or Heart Disease
This study measures how a health improvement program helps people with type 2 diabetes, chronic lung disease, or heart disease. Researchers will track your health before and after you participate in the program offered by your local municipality.
FrederiksværkAges 18 years+ - NCT06595784Recruiting
COPD and heart disease study
This study looks at people who have both COPD (a long-term lung condition) and a heart problem. The goal is to learn more about how these two conditions affect each other and to help doctors provide better care.
AlexandroupoliAges 35–99 - NCT07493629Recruiting
Study on immune status and disease control in inflammatory airway diseases
This study looks at how the immune system works and how well diseases like asthma, COPD, and others are controlled. You may join if you have one of these conditions or if you are a healthy volunteer or smoker without lung disease.
Ningbo, ZhejiangAges 18 years+ - NCT07537517Recruiting
Understanding heart failure and blood vessel pressure changes
This research study examines how certain biological pathways work in patients with heart failure who need heart catheterization (a procedure to measure heart pressures). By understanding these pathways, researchers hope to develop better treatments for pulmonary hypertension, a condition where blood pressure in the lungs becomes dangerously high.
Madrid, MadridAges 18 years+ - NCT07174102Recruiting
Looking at lung scans in rheumatoid arthritis and related diseases
This trial studies lung scans (HRCT) from patients with rheumatoid arthritis, interstitial lung disease, or connective tissue disease to better understand lung involvement. If you have one of these conditions and have had a lung CT, you may be able to help.
PragueAges 18 years+ - NCT07214376Recruiting
Nerve ablation for pulmonary hypertension from left heart disease
This trial tests a device that uses a catheter to deliver energy to nerves around the pulmonary arteries, aiming to reduce high blood pressure in the lungs caused by left heart failure. It is for people with ongoing heart failure symptoms despite optimal medications.
Tucson, ArizonaAges 18–85 - NCT01776398Recruiting
Donating breath, blood, and urine samples for lung research
This study collects airway samples (usually during a bronchoscopy), plus blood and/or urine, to help researchers study lung conditions. It may help advance understanding of lung disease and related biology, but it is not a treatment trial.
New York, New YorkAges 18 years+ - NCT05798923RecruitingPhase 2
Study of a new drug for pulmonary hypertension with lung disease
This trial tests an investigational drug called LAM-001 for people who have pulmonary hypertension (high blood pressure in the lungs) along with a type of lung disease called interstitial lung disease. The drug may help improve symptoms and daily function. This study will see if the drug is safe and helpful for this condition.
Tucson, ArizonaAges 18–85 - NCT06326957Recruiting
Online program for chronic breathlessness
This trial tests an internet-based self-guided program to help adults with chronic breathlessness. It is designed for people who still feel short of breath despite treatment for conditions like COPD, lung disease, or cancer.
LondonAges 18–110
Hear when a new Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary disease?
- Yes. Clin2 currently lists 551 recruiting pulmonary disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.